North America Gastric Buttons Market

The North America gastric buttons market is projected to grow from US$ 185.78 million in 2022 to US$ 289.97 million by 2028; it is estimated to record at a CAGR of 7.7% from 2022 to 2028.

Increasing Prevalence of Cancer, Neurological Disorders, Diabetes, and Gastrointestinal Diseases Drives Market Growth

Diabetes is a life-threatening chronic disease with no functional cure. It can lead to various complications in different body parts and increase the overall risk of premature death. Heart attack, stroke, kidney failure, leg amputation, vision loss, and nerve damage are the major complications associated with diabetes. According to the International Diabetes Federation (IDF), the number of diabetic patients in North America is projected to rise from 46 million in 2017 to 62 million by 2045. The diet of diabetic patients requires enteral nutritional support and diabetes-specific formulas.

Cancer is a leading cause of death worldwide. According to the American Society of Clinical Oncology (ASCO), head and neck cancer accounts for ~4% of all cancers in the US. Maintaining proper nutrition during cancer treatment is essential. When cancer patients struggle with nutrition, physicians opt for gastric buttons to ensure the intake of vitamins, minerals, calories, protein, and fluids in their bodies. Appropriate nutritional intake helps patients fight infection and stay healthy during the treatment, enabling overall healing.

Neurological disorders such as Parkinson's disease, dementia, epilepsy and seizures, autism, cerebral palsy, and Alzheimer's disease affect the brain and nerves of the human body. In the US, the prevalence of neurological disorders is increasing. Alzheimer's disease is a common cause of dementia, characterized by a gradual decline in memory, thinking, behavior, and social skills; these changes affect a person's ability to function. The disease prevalence is expected to increase by ~35% during the forecast period. According to the Alzheimer's Association, 5.7 million people in the Americas had Alzheimer's disease in 2018. According to the Centers for Disease Control and Prevention (CDC), Alzheimer's disease is one of the top 10 leading causes of death in the US. In 2020, the disease affected 5.8 million people in the country. Similarly, according to the Parkinson's Foundation Prevalence Project, ~930,000 individuals with Parkinson's Disease were present in the US in 2020. Epilepsy is a noncommunicable chronic brain disease that affects people of all ages. Almost 80% of people with epilepsy live in low- and middle-income countries. The same source estimates that up to 70% of people with epilepsy could live seizure-free with proper diagnosis and treatment. Weight loss and malnutrition due to suboptimal oral intake are common in patients with neurological disorders and are associated with increased disability, morbidity, and mortality. The nutritional management of patients with these diseases is crucial, and enteral feeding is a commonly used method to provide nutritional support.

Gastrointestinal diseases affect the gastrointestinal (GI) tract. Common GI disorders include irritable bowel syndrome (IBS), acid reflux, indigestion, colon cancer, and hemorrhoids. According to the data published by International Foundation for Gastrointestinal Disorders, ~40% of all IBS patients have a mild condition, ~35% have a moderate condition, and ~25% have a severe condition. Certain factors such as food allergies, developing gastroenteritis stages, sporadic colon movements, colon’s abnormal serotonin composition, and mild celiac disease are among the risk factors that cause irritable bowel syndrome. Pancreatic diseases, liver diseases, and inflammatory bowel diseases (IBDs) are often associated with nutritional difficulties and require adequate nutrition to support medical treatment.

Gastrostomy buttons are used as the enteral route of choice by many doctors. Moreover, they confer a cosmetic advantage as they can be kept hidden under clothing. Once placed, the buttons can be used for several days. With the increasing incidence of chronic diseases in North America, gastrostomy buttons are increasingly being adopted for the administration of food and medicine over the last 5 years. 

North America Gastric Buttons Market Overview

The North America gastric buttons market has been segmented into the US, Canada, and Mexico. The US held the largest share of the market in 2021. The increasing prevalence of chronic diseases, the rising research and development activities by major healthcare businesses, surging expenditure on patient care, and increasing preference for enteral nutrition drive the growth of the gastric buttons market in North America.

North America Gastric Buttons Market Revenue and Forecast to 2028 (US$ Million)

North America Gastric Buttons Strategic Insights

Strategic insights for the North America Gastric Buttons provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

North America Gastric Buttons Report Scope

North America Gastric Buttons Regional Insights

The geographic scope of the North America Gastric Buttons refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

North America Gastric Buttons Market Segmentation

The North America gastric buttons market is segmented on the basis of offering, application, usage, end user, and country. Based on offering, the market is bifurcated into products and accessories. The products segment held a larger market share in 2022. Further, accessories are categorized as button feeding sets, button decompression sets, and others.

Based on application, the North America gastric buttons market is bifurcated into children and adults. The children segment held a larger market share in 2022.

Based on usage, the North America gastric buttons market is segmented into enteral nutrition, medications, fluids, and others. The enteral nutrition segment held the largest market share in 2022.

Based on end user, the North America gastric buttons market is segmented into hospitals, clinics, and others. The hospitals segment held the largest market share in 2022. 

Based on country, the North America gastric buttons market is segmented into the US, Canada, and Mexico. The US dominated the market in 2022.

Avanos Medical Inc., Boston Scientific Corp, QMD, Shin-Etsu Polymer Europe BV, Applied Medical Technology Inc., Vygon (UK) Ltd, and Fresenius Kabi AG are the leading companies operating in the North America gastric buttons market.